Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives $92.17 Average Price Target from Analysts
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given an average recommendation of “Buy” by the six research firms that are currently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have covered the stock in […]
Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Get Free Report) have been given an average recommendation of “Buy” by the six research firms that are currently covering the firm, MarketBeat reports. Six analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have covered the stock in […]
